Hospital services like those provided by Omnicell, Inc. (OMCL) should exhibit strong growth over the long-term, benefiting from favorable demographic trends, regulatory environments and a lack of nursing staff. The market also remains underpenetrated.

Moreover, the U.S. government’s approval of more than $20 billion in healthcare IT is likely to boost Omnicell’s top-line. A slowly recovering economy will also help the company going forward.

Based on the company’s strong long-term outlook, we upgrade the stock to Outperform with a target price of $15.50. This is based on a P/S multiple of 2.2x our fiscal 2010 revenue estimate.

Zacks Investment Research

1. (OMCL) Omnicell Analyst Upgrades SharesWe recently upgraded Omnicell, Inc. (OMCL) to an ‘Outperform’ with a target price of $15.50...
2. (DV) DeVry Incorporated – Bull of the DayDeVry, Inc. (DV) is a leading provider of post secondary education in North America and...
3. (OMCL) Omnicell Analysts Maintain Neutral RatingWe recently reiterated our Neutral rating on Omnicell, Inc. (OMCL) with a target price of...
4. (OMCL) Omnicell Enters New Contract With Carolinas HealthCare SystemOmnicell, Inc. (OMCL) recently entered into a new contract with Carolinas HealthCare System (CHS) whereby...
5. (OMCL) Omnicell Launches New ProductOmnicell, Inc. (OMCL) recently launched a new product, Omnicell 14.0 with Anywhere RN, a software...
6. (OMCL) Omnicell Eclipses Consensus EstimateOmnicell Inc. (OMCL) reported third quarter 2009 earnings per share of 10 cents yesterday, beating...

Search Posts by Tag: OMCL | Omnicell Inc. | Computer Based Systems | Technology

RSS Feeds by Tag: OMCL | Omnicell Inc. | Computer Based Systems | Technology |

Other Posts by: vitalstocks | RSS Feed for this author